Form 4: Apellis Pharmaceuticals VP James Chopas Sells Shares to Cover Tax Withholding
SEC Form 4 Filing
James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 183 shares of common stock on March 17, 2025, to cover tax withholding obligations.
Summary
- On March 17, 2025, James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 183 shares of the company's common stock.
- The shares were sold at a price of $24.8237 per share.
- The sale was executed to cover tax withholding obligations related to the release of Restricted Stock Units on March 14, 2025.
- Following the transaction, Chopas directly owns 47,955 shares of Apellis Pharmaceuticals.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction to cover tax obligations, not indicative of a significant change in the company's prospects or the insider's confidence.
Industry Context
This is a routine Form 4 filing, indicating a transaction by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Restricted Stock Units released |
| 03/17/2025 | Date of stock sale |
| 03/18/2025 | Date of signature on Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.